Fiera Capital Corp

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1505817 MONTREAL, A8

Position in XENE

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$41,259,110

+$10,510,081 QoQ

Shares Held

709,529

+3.4% QoQ

Ownership

0.734%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 35.73046344828752.ToString("F0")% Shared 2.3036408659829264.ToString("F0")% None 61.96589568572954.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fiera Capital Corp holds $821,046,758 across 19 Biotechnology names. XENE ranks #5 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	1,021,970	$167,112,534
2	ARGX	Argenx SE	217,198	$158,608,839
3	MDGL	Madrigal Pharmaceuticals, Inc.	174,011	$91,089,537
4	IDYA	IDEAYA Biosciences, Inc.	2,527,076	$84,202,171
5	XENE	Xenon Pharmaceuticals Inc. This page	709,529	$41,259,110
6	TERN	Terns Pharmaceuticals, Inc.	711,326	$37,501,106
7	IMCR	Immunocore Holdings plc	1,080,099	$32,564,984
8	LGND	Ligand Pharmaceuticals Inc	135,312	$27,015,040

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,259,110	709,529	+3.4%	Shares	Sole	2026-05-12
2025-12-31	$30,749,029	686,056	+31.9%	Shares	Other	2026-02-11
2025-09-30	$20,877,959	519,999	-2.0%	Shares	Other	2025-11-07
2025-06-30	$16,610,377	530,683	+0.2%	Shares	Other	2025-08-08
2025-03-31	$17,762,778	529,442	-1.2%	Shares	Sole	2025-05-07
2024-12-31	$21,006,769	535,887	-3.3%	Shares	Other	2025-01-29
2024-09-30	$21,818,853	554,200	-4.9%	Shares	Other	2024-11-01
2024-06-30	$22,726,451	582,879	+1.1%	Shares	Sole	2024-10-31
2024-03-31	$24,820,132	576,542	+4.3%	Shares	Sole	2024-08-22
2023-12-31	$25,472,561	553,030	-1.3%	Shares	Sole	2024-08-22
2023-09-30	$19,148,250	560,546	+2.0%	Shares	Other	2024-08-22
2023-06-30	$21,149,628	549,341	—	Shares	Other	2023-08-09
No filing history on record for this holder in this stock.